Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer–High Responder (MEGASET-HR) trial

OBJECTIVE: To determine the cost of achieving a live birth after first transfer using highly purified human menotropin (HP-hMG) or recombinant follicle-stimulating hormone (FSH) for controlled ovarian stimulation in predicted high-responder patients in the Menopur in Gonadotropin-releasing hormone A...

Descripción completa

Detalles Bibliográficos
Autores principales: Robins, Jared C., Khair, Andrew F., Widra, Eric A., Alper, Michael M., Nelson, Winnie W., Foster, Eric D., Sinha, Anshul, Ando, Masakazu, Heiser, Patrick W., Daftary, Gaurang S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244378/
https://www.ncbi.nlm.nih.gov/pubmed/34223253
http://dx.doi.org/10.1016/j.xfre.2020.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244378/
https://www.ncbi.nlm.nih.gov/pubmed/34223253
http://dx.doi.org/10.1016/j.xfre.2020.09.010

Ejemplares similares